1. Small RNAs, Big Diseases
    Iwona Rzeszutek et al, 2020, International Journal of Molecular Sciences CrossRef
  2. MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma
    Seung-Myoung Son et al, 2023, BMC Cancer CrossRef
  3. Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases
    Qi-Yuan Huang et al, 2019, International Journal of Molecular Sciences CrossRef
  4. Machine Learning Approach for Predicting Past Environmental Exposures From Molecular Profiling of Post-Exposure Human Serum Samples
    Atif Khan et al, 2019, Journal of Occupational & Environmental Medicine CrossRef
  5. The landscape of long non-coding RNAs in tumor stroma
    Md. Nazim Uddin et al, 2021, Life Sciences CrossRef
  6. MicroRNA-29a suppresses the growth of human cervical cancer cells by targeting cell division cycle 42 (CDC42)
    Fang Song et al, 2021, Journal of Taibah University for Science CrossRef
  7. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients
    Wenjun Liu et al, 2018, Cancer Biomarkers CrossRef
  8. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer
    Rong Chen et al, 2019, Anti-Cancer Drugs CrossRef
  9. MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
    Xin Liu et al, 2018, Technology in Cancer Research & Treatment CrossRef
  10. Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates
    Xing-Hua Xiao et al, 2018, Molecules CrossRef
  11. Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients
    Matthias Bache et al, 2023, International Journal of Molecular Sciences CrossRef
  12. Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1
    Yu Hu et al, 2020, Molecular Medicine CrossRef
  13. SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
    Fei Cui et al, 2020, Molecular Genetics & Genomic Medicine CrossRef
  14. MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4
    Ke Mao et al, 2017, International Journal of Oncology CrossRef
  15. MiR-29a: a potential therapeutic target and promising biomarker in tumors
    Jin-yan Wang et al, 2018, Bioscience Reports CrossRef
  16. Detection of a miRNA biomarker for cancer diagnosis using SERS tags and magnetic separation
    Kiatnida Treerattrakoon et al, 2022, Analytical Methods CrossRef
  17. miR-29a Negatively Affects Glucose-Stimulated Insulin Secretion and MIN6 Cell Proliferation via Cdc42/β-Catenin Signaling
    Jing Duan et al, 2019, International Journal of Endocrinology CrossRef
  18. Investigating potential molecular mechanisms of serum exosomal miRNAs in colorectal cancer based on bioinformatics analysis
    Haifeng Wang et al, 2020, Medicine CrossRef